跳至主要内容
临床试验/IRCT20180517039694N1
IRCT20180517039694N1尚未招募3 期

Evaluating the effect of oral nano formulation of silymarin in non metastatic prostate cancer patients after radical prostatectomy

Mashhad University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 years 至 75 years(—)
性别
Male

入选标准

  • Intermediate_risk prostate cancer with gleason score<8
  • Life expectancy more than 10 years

排除标准

  • Patient with history of chemotherapy,radiotherapy or hormone therapy
  • Patient with chronic liver or kidney or heart disease
  • Patient with diabetes mellitus
  • Patient with autoimmune disease
  • History of hypersensitivity to silymarin
  • concomitant use of anti inflammatory drugs or other antioxidant
  • Patient disagreement

研究者

相似试验

Efficacy of oral silymarin formulation on prostate... | 临床试验